Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Mistrangelo

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Updates in Surgery|June 20, 2021
Oral neomycin and bacitracin are effective in preventing surgical site infections in elective colorectal surgery: a multicentre, randomized, parallel, single-blinded trial (COLORAL-1)Alberto Arezzo, Massimiliano Mistrangelo, Marco Augusto Bonino, et al.
Cancer Investigation|June 29, 2018
Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiationPierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, et al.
Gastroenterology Research and Practice|May 11, 2018
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter StudyGaetano Gallo, Massimiliano Mistrangelo, Roberto Passera, et al.
Cancer Investigation|May 8, 2015
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case seriesPierfrancesco Franco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2012
Role of positron emission tomography-computed tomography in the management of anal cancerMassimiliano Mistrangelo, Ettore Pelosi, Marilena Bellò, et al.
Plos One|April 16, 2015
YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyRebecca Senetta, Eleonora Duregon, Cristina Sonetto, et al.
Journal of Personalized Medicine|June 2, 2021
Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II TrialFrancesca Arcadipane, Patrick Silvetti, Francesco Olivero, et al.
Radiation Oncology (London, England)|September 12, 2018
Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational studyPierfrancesco Franco, Berardino De Bari, Francesca Arcadipane, et al.
Updates in Surgery|August 28, 2025
Consider the unexpected! An overlooked, elusive, rare but dramatic diagnosis: anorectal melanomaRossella Melcarne, Chiara Eberspacher, Massimiliano Mistrangelo, et al.
Surgery|April 13, 2021
FISSIT (Fistula Surgery in Italy) study: A retrospective survey on the surgical management of anal fistulas in Italy over the last 15 yearsFrancesco Litta, Salvatore Bracchitta, Gabriele Naldini, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Updates in Surgery|June 20, 2021
Oral neomycin and bacitracin are effective in preventing surgical site infections in elective colorectal surgery: a multicentre, randomized, parallel, single-blinded trial (COLORAL-1)Alberto Arezzo, Massimiliano Mistrangelo, Marco Augusto Bonino, et al.
Cancer Investigation|June 29, 2018
Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiationPierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, et al.
Gastroenterology Research and Practice|May 11, 2018
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter StudyGaetano Gallo, Massimiliano Mistrangelo, Roberto Passera, et al.
Cancer Investigation|May 8, 2015
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case seriesPierfrancesco Franco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2012
Role of positron emission tomography-computed tomography in the management of anal cancerMassimiliano Mistrangelo, Ettore Pelosi, Marilena Bellò, et al.
Plos One|April 16, 2015
YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyRebecca Senetta, Eleonora Duregon, Cristina Sonetto, et al.
Journal of Personalized Medicine|June 2, 2021
Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II TrialFrancesca Arcadipane, Patrick Silvetti, Francesco Olivero, et al.
Radiation Oncology (London, England)|September 12, 2018
Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational studyPierfrancesco Franco, Berardino De Bari, Francesca Arcadipane, et al.
Updates in Surgery|August 28, 2025
Consider the unexpected! An overlooked, elusive, rare but dramatic diagnosis: anorectal melanomaRossella Melcarne, Chiara Eberspacher, Massimiliano Mistrangelo, et al.
Surgery|April 13, 2021
FISSIT (Fistula Surgery in Italy) study: A retrospective survey on the surgical management of anal fistulas in Italy over the last 15 yearsFrancesco Litta, Salvatore Bracchitta, Gabriele Naldini, et al.
Pageof 7